<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03276650</url>
  </required_header>
  <id_info>
    <org_study_id>PSS2017/Still-ICU-LEMARIE/VS</org_study_id>
    <nct_id>NCT03276650</nct_id>
  </id_info>
  <brief_title>Admission of Adult-onset Still Disease Patients in the ICU</brief_title>
  <acronym>Still-ICU</acronym>
  <official_title>Admission of Adult-onset Still Disease Patients in the ICU: a French Retrospective Multicentric Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since its first description in 1971, diagnosing adult-onset Still's disease (AOSD), a rare
      multisystemic disorder considered as a multigenic autoinflammatory syndrome, remains
      challenging. Rarely, AOSD may present severe systemic manifestations and require intensive
      care. The main purpose of the Stil ICU study is to make the first description of the
      epidemiology of critically ill AOSD patients. The investigators will use a retrospective
      cohort study design with dual recruitment strategies: (1) via the AOSD referral centres
      network and (2) via a French academic medical ICU network.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of patients</measure>
    <time_frame>At inclusion</time_frame>
    <description>Number of patients fulfilling the inclusion criteria</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>APACHE II</measure>
    <time_frame>24hour after ICU admission</time_frame>
    <description>Acute Physiologic Assessment and Chronic Health Evaluation II</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>through study completion, maximum 17,5 years after admission</time_frame>
    <description>Kaplan Meier</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of rehospitalisation in ICU</measure>
    <time_frame>through study completion, maximum 17,5 years after admission</time_frame>
    <description>need for critical care after the first hospitalisation in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of hospitalisation in internal medicine ward</measure>
    <time_frame>through study completion, maximum 17,5 years after admission</time_frame>
    <description>number of hospitalisation in internal medicine ward after the first ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recurrent relapses</measure>
    <time_frame>through study completion, maximum 17,5 years after admission</time_frame>
    <description>number of recurrent flares after the first hospitalisation in ICU</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Adult-Onset Still Disease</condition>
  <condition>Critically Ill</condition>
  <arm_group>
    <arm_group_label>critically ill AOSD patients</arm_group_label>
    <description>no intervention Data collection from hospitalisation reports (administrative, biological, clinical, outcome)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>data collection</intervention_name>
    <description>biological, administrative, clinical, outcome date</description>
    <arm_group_label>critically ill AOSD patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult AOSD patients admitted to ICU
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  AOSD (history of newly diagnosed)

          -  ICU admission between January 2001 and June 2017

        Exclusion Criteria:

          -  adults under protection

          -  admission in step-down unit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jérémie Lemarié, MD</last_name>
    <phone>+3383851504</phone>
    <email>j.lemarie@chru-nancy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeremie Lemarie, PD PHD</last_name>
      <phone>003383851505</phone>
      <email>j.lemarie@chru-nancy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2017</study_first_submitted>
  <study_first_submitted_qc>September 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 8, 2017</study_first_posted>
  <last_update_submitted>February 1, 2018</last_update_submitted>
  <last_update_submitted_qc>February 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Arthritis, Juvenile</mesh_term>
    <mesh_term>Still's Disease, Adult-Onset</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

